Baumer

Baumer Cash Conversion Cycle

The Cash Conversion Cycle (CCC) of Baumer (BALM4.SA) as of Nov 15, 2026 is 228.73. In the previous year, Cash Conversion Cycle (CCC) was 256.04 — a change of -10.67% (lower).

Cash Conversion Cycle

228.73

YoY

-10.67%

Last updated:

Cash Conversion Cycle (CCC) of Baumer is 2024 228.73 . Cash Conversion Cycle (CCC) of Baumer was 2023 256.04 . It decreases by -10.67% lower compared to the previous year.

The Baumer Cash Conversion Cycle history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion Cycle
Date
Cash Conversion Cycle
Jan 1, 2017
413.89 BRL
Jan 1, 2018
453.12 BRL
Jan 1, 2019
318.56 BRL
Jan 1, 2020
253.92 BRL
Jan 1, 2021
353.76 BRL
Jan 1, 2022
330.73 BRL
Jan 1, 2023
256.04 BRL
Jan 1, 2024
228.73 BRL
The Baumer Cash Conversion Cycle history
YEARCash Conversion CycleYoY
228.73-10.67%
256.04-22.58%
330.73-6.51%
353.76+39.32%
253.92-20.29%
318.56-29.70%
453.12+9.48%
413.89+4.01%
397.95-0.20%
398.75+20.43%
331.11—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Baumer Stock analysis

What does Baumer do? Baumer SA generates revenue through the sale of medical equipment and solutions across its four business units. The Orthopedic unit produces and sells orthopedic implants and instruments, while the Hospital unit manufactures equipment for hospitals and industries including pharmaceutical, chemical, cosmetic, and food sectors. The Genius unit focuses on biomaterials, and the Brown unit supplies laundry equipment for hospitals, industrial, and hotel settings. The company's subsidiaries, Hospitalar Sul Ltda and Waldsea Investment SA, support its operations as of December 31, 2011. The primary buyers of Baumer SA's products include hospitals, pharmaceutical companies, chemical manufacturers, cosmetic firms, and food industry businesses. Additionally, industrial and hotel sectors purchase the laundry equipment from the Brown unit. The company's technical assistance services for medical apparatus also contribute to its revenue stream. Baumer SA's business model relies on direct sales of its specialized equipment and solutions to healthcare and industrial clients. The firm's product portfolio spans orthopedic care, hospital infrastructure, biomaterials, and laundry systems, catering to both medical and non-medical industrial applications. This diversified approach allows the company to serve multiple segments within the health and industrial markets. Baumer is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Baumer stock

Cash Conversion Cycle (CCC) of Baumer is 228.73 in 2024.

Cash Conversion Cycle (CCC) of Baumer changed from 256.04 to 228.73, representing a -10.67% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Cycle (CCC) Baumer since 2006 – with annual values, charts, and detailed analysis.

The Cash Conversion Cycle measures how long it takes to convert inventory investments into cash from sales. A shorter CCC indicates more efficient working capital management.

CCC = DSO + DIO - DPO

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Cycle (CCC)'s Baumer with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Cycle (CCC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Cycle (CCC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Baumer

All Key Metrics — Baumer